Código QR (código de barras bidimensional)

Transition from reference adalimumab to biosimilar SB5 in patients with rheumatoid arthritis: sub-analysis of Spanish patients in the PROPER study

This sub-analysis of the PROPER study aimed to evaluate outcomes following the transition from reference adalimumab (ADL) to SB5 (Imraldi™) in routine clinical practice in Spanish patients with rheumatoid arthritis (RA). Adult Spanish patients (n = 73) with RA who initiated SB5 as part of routine cl...

Fuld beskrivelse

Na minha lista:
Principais autores: Fernando Pérez-Ruiz, Begoña Olivares Paret, Eugenio Chamizo Carmona
Format: Artigo
Sprog:Inglês
Udgivet: Open Exploration Publishing Inc. 2025-02-01
Serier:Exploration of Musculoskeletal Diseases
Fag:
adalimumab
biologics
biosimilars
rheumatoid arthritis
sb5
treatment switching
Online adgang:https://www.explorationpub.com/uploads/Article/A100784/100784.pdf
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker